The Effects of Jack Inhibitors on Malignancy

In the future we're hoping to look at particularly malignancy event rates VTE and MACE event rates with jack inhibitors and other published so that's what we're hope to look at soon. Do you think the EMA was correct to say that anyone at risk of cancer should not take a jack or should that really have been people with a current non malignancy skin cancer should be careful? I do think it makes their job somewhat more difficult in that we have such an efficacious class of drugs that we were using very frequently and now we're certainly can't do anything but make you somewhat more cautious, he said.